Cargando…
Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
BACKGROUND: Varenicline is an efficacious smoking‐cessation drug. However, previous meta‐analyses provide conflicting results regarding its cardiovascular safety. The publication of several new randomized controlled trials (RCTs) provides an opportunity to reassess this potential adverse drug reacti...
Autores principales: | Sterling, Lee H., Windle, Sarah B., Filion, Kristian B., Touma, Lahoud, Eisenberg, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802486/ https://www.ncbi.nlm.nih.gov/pubmed/26903004 http://dx.doi.org/10.1161/JAHA.115.002849 |
Ejemplares similares
-
A Randomized Controlled Trial Evaluating the Efficacy of E-Cigarette Use for Smoking Cessation in the General Population: E3 Trial Design
por: Hébert-Losier, Andréa, et al.
Publicado: (2020) -
Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis
por: Thomas, Kyla H, et al.
Publicado: (2015) -
Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis
por: Prochaska, Judith J, et al.
Publicado: (2012) -
Effectiveness of interventions for prevention of common infections in people who use opioids: a protocol for a systematic review of systematic reviews
por: Kudrina, Irina, et al.
Publicado: (2021) -
Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials
por: Chang, Ping-Hsun, et al.
Publicado: (2015)